low back pain Guide

Clinical Trials For Low Back Pain Section


   
Social bookmarking
You like it? Share it!
socialize it

Newsletter

Subscribe to our newsletter AND receive our exclusive Special Report on low-back-pain
Email:
First Name:



Main Clinical Trials For Low Back Pain sponsors

  

Latest Clinical Trials For Low Back Pain link added

...

Submit your link on Clinical Trials For Low Back Pain!



 

Welcome to low back pain Guide

   

Clinical Trials For Low Back Pain Article

Thumbnail example. For a permanent link to this article, or to bookmark it for further reading, click here.


You may also listen to this article by using the following controls.

Lower Back Pain

from:

Lower back pain is a sudden, persistent, sharp or dull pain felt below the waist. It is common and affects most people at some point in their life. Lower back pain is commonly caused by muscle strain from heavy physical lifting, work, or forceful movement, twisting or bending, awkward positions, or standing in one position for too long. Any of these things can also make a prior or existing back disorder feel much worse.

There are other conditions that can cause lower back pain. They include spinal stenosis, spinal infection, arthritis, spinal tumors, spondylolisthesis and fractures of the vertebrae.

Lower back pain is either chronic or acute. Chronic is persistent, long term pain, occasionally lasting throughout one's life. However, even chronic pain can have bouts of acute pain. Acute lower back pain may begin quickly with intense pain and lasts less than three months.

Other symptoms of lower back pain include pain in a specific area of the lower back, general aching, pain that radiates in the buttocks, low back, or legs. Occasionally the pain is accompanied by neurological symptoms such as tingling, weakness, and numbness. The neurological symptoms that may require immediate medical attention include bladder or bowel dysfunction, leg or groin weakness or numbness, severe symptoms that do not ease after a few day or pain that prohibits regular activities.

There are several myths about lower back pain. Lower back pain is not always caused by a slipped or herniated disc. In fact, only one to three percent of lower back pain is caused by this. In addition, few people with lower back pain will require surgery. Also, MRIs are very useful in diagnosing lower back pain, however not everyone will need one and it is not a treatment. Not everyone has lower back pain, either. In fact, getting assistance early is important to successful treatment as it can reduce the number of times the back pain recurs. There are other factors, too, that increase the risk of people developing lower back pain. They include being overweight, driving, smoking, and sitting for long periods. Up to ninety percent of adults will experience lower back pain at some point in their life.

It is common to experience lower back pain like a sprained ankle. In addition, while lower back pain can be debilitating and severe to many people, often the pain improved without the need for surgery. Half of all patients with lower back pain will have a second episode within one year. If lower back pain occurs with a fever or can be associated with a specific injury, the person suffering should consult their physician immediately or visit the emergency room. If there is no fever or cannot be associated with a specific injury, a conservative treatment at home for two or three days can be administered by the person.

Taking care of your back, however, is the key to ensuring that you rarely or never suffer from lower back pain. When you do, do not treat your back any differently to avoid the aches and pains that are associated with back pain.


Other Clinical Trials For Low Back Pain related Articles

Chronic Low Back Pain
Lower Back Pain
Lower Back Pain In Women
Low Back Pain
Lower Back Pain With Stomach Pain

Do you want to contribute to our site : submit your articles HERE


 

Clinical Trials For Low Back Pain News

The Stats on Statins: Should Healthy Adults Over 50 Take Them?

Everyone over 50 should take statins to lower their cholesterol, an editorial argued last week in The Lancet . The piece based its recommendation on a meta-analysis of 27 clinical trials published in the same issue that concluded statins significantly reduce the risk of heart attacks and other cardiovascular events in healthy people without posing substantial risks. Subsequent articles heralding ...

Read more...


Mixed evidence on acupuncture for irritable bowels

NEW YORK (Reuters Health) - The research on whether acupuncture helps ease irritable bowel syndrome has so far been a mixed bag, according to a new review of past clinical trials. The review, published in the American Journal of Gastroenterology, found that in some trials, acupuncture seemed to work better than certain medications for irritable bowel syndrome, or IBS. Yet in others, acupuncture ...

Read more...


Zyga Technology Announces $25 Million Venture Financing

MINNEAPOLIS, May 16, 2012 /PRNewswire/ -- Zyga Technology announced today that it had raised $25 million in a Series C financing led by new investor Versant Ventures of Menlo Park, California.  Joining ...

Read more...


Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012

Genentech, a member of the Roche Group , today announced that the company will present important new data from studies of several of its cancer medicines at the 48th Annual Meeting of the American Society of Clinical Oncology , June 1 to 5, 2012, in Chicago.

Read more...


From silencing snoring to easing depression, how doctors are using jolts of electricity to improve our health

Some forms of electrical treatment are well-established but there are myriad new uses, from treating diabetes to incontinence.

Read more...


FDA approves Protalix's Gaucher drug Elelyso

The Food and Drug Administration on Tuesday approved a new treatment for Gaucher disease, a rare genetic disorder that can cause liver and neurological problems.

Read more...


Nordion Announces Europe-Focused Phase III Clinical Trial for TheraSphere® Liver Cancer Treatment

Study to evaluate and compare safety and efficacy of TheraSphere® vs. sorafenib in hepatocellular carcinoma patients with portal vein thrombosis OTTAWA, April 24, 2012 /PRNewswire/ - Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the...

Read more...